List of articles in "Drug" category - Page 174

Robatumumab (proposed INN) is a monoclonal antibody and an antineoplastic by Schering-Plough. It binds to CD221 the insulin-like growth factor 1 receptor.

Panobacumab (proposed INN) is a monoclonal antibody designed as an antibacterial against Pseudomonas aeruginosa.It is a fully human pentameric IgM antibody with a mouse J chain.

Oportuzumab monatox (proposed INN) is an antineoplastic. Chemically oportuzumab it is a single chain variable fragment of a monoclonal antibody which binds to epithelial cell adhesion molecule (EpCAM the tumor-associated […]

Necitumumab (proposed INN) is a monoclonal antibody and an antineoplastic. It binds to the epidermal growth factor receptor (EGFR). As of October 2009 two Phase III clinical trials are planned […]

Hycanthone is the schistosomicide approved by the FDA in 1975. It is a metabolite of lucanthone. Hycanthone interferes with parasite nerve function resulting in paralysis and death. This agent also […]

Bithionol is an anthelmintic used to treat Anoplocephala perfoliata (tapeworms) in horses and Fasciola hepatica (liver flukes).

Stibophen is an anthelmintic classified as antimony compound and used as treatment of schistosomiasis by intramuscular injection.

Desaspidin is an anthelmintic. Desapidin may occur in natural form within some plants such as Coastal woodfern Dryopteris arguta. Since the 1950s the inhibition effects of desapidins upon phosphorylation in […]

Flubendazole is an anthelmintic. Its brand name is Flutelmium which is a paste manufactured by Janssen Pharmaceutica N.V. used by veterinarians for protection against internal parasites and worms in dogs […]